HCID 10101472, compound → HCID 11764742, compound
Reaction equation
C([N:8]1[CH2:13][CH2:12][CH:11]([N:14]2[CH2:19][CH2:18][N:17]([C:20](=[O:54])[C@H:21]([NH:33][C:34]([N:36]3[CH2:41][CH2:40][CH:39]([N:42]4[CH2:48][CH2:47][C:46]5[CH:49]=[CH:50][CH:51]=[CH:52][C:45]=5[NH:44][C:43]4=[O:53])[CH2:38][CH2:37]3)=[O:35])[CH2:22][C:23]3[CH:32]=[CH:31][C:30]4[CH2:29][CH2:28][CH2:27][CH2:26][C:25]=4[CH:24]=3)[CH2:16][CH2:15]2)[CH2:10][CH2:9]1)C1C=CC=CC=1.[H][H]>CO.[Pd]>[O:54]=[C:20]([N:17]1[CH2:18][CH2:19][N:14]([CH:11]2[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]2)[CH2:15][CH2:16]1)[C@H:21]([NH:33][C:34]([N:36]1[CH2:37][CH2:38][CH:39]([N:42]2[CH2:48][CH2:47][C:46]3[CH:49]=[CH:50][CH:51]=[CH:52][C:45]=3[NH:44][C:43]2=[O:53])[CH2:40][CH2:41]1)=[O:35])[CH2:22][C:23]1[CH:32]=[CH:31][C:30]2[CH2:29][CH2:28][CH2:27][CH2:26][C:25]=2[CH:24]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 100 mg (0.14 mmol) 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylic acid [(R)-2-[4-(1-benzyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(5,6,7,8-tetrahydro-naphthalen-2-ylmethyl)-ethyl]-amide (Example 50) in 10 mL MeOH was hydrogenated in the presence of 20 mg Pd/C (10%) at 50° C. and 3 bar hydrogen pressure until the calculated volume of hydrogen had been taken up. The catalyst was filtered off, the solvent eliminated under reduced pressure and the residue purified by chromatography on silica gel. The product fractions were evaporated down under reduced pressure and dried.
Workup
- filtrationThe catalyst was filtered off
- customthe residue purified by chromatography on silica gel
- customThe product fractions were evaporated down under reduced pressure
- customdried
Sources & evidence
- ORD record
- ord-0eacfc883a9042bdb809ddd98dd3432f
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07700589B2
Reaction notes
Loading…